Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration

Thomas M Hallam; Emanuela Gardenal; Fraser McBlane; GaEun Cho; Lucy Lee Ferraro; Eva Pekle; Darlene Lu; Kate Carney; Claire Wenden; Hannah Beadsmoore; Sergio Kaiser; Lauren Drage; Thomas Haye; Iris Kassem; Nalini Rangaswamy; Ma’en Obeidat; Cyndy Grosskreutz; Magali Saint-Geniez; David H Steel; Robert E MacLaren; FOCUS Principal Investigators; Scott Ellis; Claire L Harris; Stephen Poor; Amy V Jones

doi:10.1101/2024.06.12.24308796

Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration

View ORCID ProfileThomas M Hallam, Emanuela Gardenal, Fraser McBlane, GaEun Cho, Lucy Lee Ferraro, Eva Pekle, Darlene Lu, Kate Carney, Claire Wenden, Hannah Beadsmoore, Sergio Kaiser, Lauren Drage, Thomas Haye, Iris Kassem, Nalini Rangaswamy, Ma’en Obeidat, Cyndy Grosskreutz, Magali Saint-Geniez, David H Steel, Robert E MacLaren, Scott Ellis, Claire L Harris, Stephen Poor, Amy V Jones FOCUS Principal Investigators

doi: https://doi.org/10.1101/2024.06.12.24308796

Thomas M Hallam

1Gyroscope Therapeutics Ltd, A Novartis Company

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Thomas M Hallam
For correspondence: thomas.hallam@novartis.com

Emanuela Gardenal

1Gyroscope Therapeutics Ltd, A Novartis Company

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fraser McBlane

3Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GaEun Cho

4Clinical Development, Global Drug Development, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lucy Lee Ferraro

4Clinical Development, Global Drug Development, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eva Pekle

1Gyroscope Therapeutics Ltd, A Novartis Company

5Biomarker Development, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Darlene Lu

6Biostatistics, Global Drug Development, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kate Carney

1Gyroscope Therapeutics Ltd, A Novartis Company

3Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claire Wenden

1Gyroscope Therapeutics Ltd, A Novartis Company

3Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hannah Beadsmoore

1Gyroscope Therapeutics Ltd, A Novartis Company

3Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sergio Kaiser

5Biomarker Development, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lauren Drage

1Gyroscope Therapeutics Ltd, A Novartis Company

7Cell and Gene Therapies, TRD, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Haye

1Gyroscope Therapeutics Ltd, A Novartis Company

7Cell and Gene Therapies, TRD, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Iris Kassem

8Ophthalmology, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nalini Rangaswamy

8Ophthalmology, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ma’en Obeidat

5Biomarker Development, Translational Medicine, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cyndy Grosskreutz

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Magali Saint-Geniez

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David H Steel

9Bioscience Institute, Newcastle University, Newcastle Upon Tyne, UK; Sunderland Eye Infirmary, Sunderland, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert E MacLaren

10Nuffield Laboratory of Ophthalmology and Oxford Eye Hospital, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott Ellis

1Gyroscope Therapeutics Ltd, A Novartis Company

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claire L Harris

1Gyroscope Therapeutics Ltd, A Novartis Company

2Translational Research, Ophthalmology, BioMedical Research, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephen Poor

4Clinical Development, Global Drug Development, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: thomas.hallam@novartis.com

Amy V Jones

1Gyroscope Therapeutics Ltd, A Novartis Company

4Clinical Development, Global Drug Development, Novartis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: thomas.hallam@novartis.com

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted June 15, 2024.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration

Thomas M Hallam, Emanuela Gardenal, Fraser McBlane, GaEun Cho, Lucy Lee Ferraro, Eva Pekle, Darlene Lu, Kate Carney, Claire Wenden, Hannah Beadsmoore, Sergio Kaiser, Lauren Drage, Thomas Haye, Iris Kassem, Nalini Rangaswamy, Ma’en Obeidat, Cyndy Grosskreutz, Magali Saint-Geniez, David H Steel, Robert E MacLaren, Scott Ellis, Claire L Harris, Stephen Poor, Amy V Jones

medRxiv 2024.06.12.24308796; doi: https://doi.org/10.1101/2024.06.12.24308796

Share This Article: